[Photo/Xinhua] A team of Chinese cardio experts have offered free cardiovascular surgical operation to 10 patients at the Komfo Anokye Teaching Hospital in Kumasi, Ghana's second most populous city. The 10-member team from China's ...
Tags: Chinese Doctors, Heart Surgeries
The famous Chinese cardiologist Zhang Shu, 56, was the main official at this year's World Congress of Arrhythmias, which was held in Beijing from Sept 17-19. As the secretary-general of the World Society of Arrhythmias that is held once ...
Tags: Chinese Doctor, Arrhythmias, ICD
Study finds salt intake not associated with heart health risks Salt intake was not associated with mortality or risk for cardiovascular disease (CVD) and heart failure (HF) in older adults based on self-reported estimated sodium ...
Tags: salt, heart health risks, Agriculture
From a zipper-like wound closure device that can be peeled off at home to a telemedicine robot, there are plenty of ingenious devices included as finalists in this year's Medical Design Excellence Awards. It is worth noting, however, that ...
Tags: Reshaping Medtech, Health, Medicine
Add AT&T to the list of high tech companies seeking to increase their visibility in the medical device industry: The Dallas–based telecommunications giant has appointed digital health notable Eric Topol, MD, as its new chief medical ...
Tags: health
US-based AliveCor has obtained the US Food and Drug Administration (FDA) approval to sell its AliveCor heart monitor without prescription, previously available by prescription only. It is claimed to be the only FDA cleared mobile ECG ...
Tags: Heart Monitor, AliveCor
The European Society of Cardiology (ESC) announced today that Rome was chosen as the venue for the ESC Congress 2016. The ESC Congress is the largest cardiology meeting in the world. This will be the first time it comes to Rome. 30,000 ...
Tags: Medicine, cardiologist
Transcatheter Technologies has announced that an independent laboratory has completed ‘advanced wear testing’ (AWT) of the company’s Trinity valve prosthesis, far exceeding minimum testing standards. Indeed, AWT of the ...
Tags: AWT, TAVI, PVL, Trinity valve
Obese American adults die an average of almost four years earlier than those with normal weight, and middle-aged obese adults face the highest risk of an early death, a new study suggests. One expert wasn't surprised by the findings. ...
Drinking green tea may lessen the effects of the medication nadolol (Corgard), used to treat high blood pressure, a new small study suggests. Researchers gave 10 volunteers a single dose of 30 milligrams of nadolol after they had consumed ...
Cutting back on exercise, or stopping altogether, might seem like the right move for people whose heart beats too fast and erratically, a condition called atrial fibrillation. But that's not necessarily so. In fact, staying active -- ...
Tags: atrial fibrillation, heart rate, heart rhythm problems, exercise
Boosting the amount of fiber in your diet may lower your risk for heart disease, a new study finds. "With so much controversy causing many to avoid carbohydrates and grains, this trial reassures us of the importance of fiber in the ...
Tags: heart disease, fiber, cardiovascular disease, fiber-rich foods
High blood pressure is a preventable and treatable risk factor for heart attack and stroke, but about one-quarter of adults don't know they have it, according to a large new study. Among those who do know they have the condition, many are ...
Tags: high blood pressure, health
Fewer people should take medicine to control their high blood pressure, a new set of guidelines recommends. Adults aged 60 or older should only take blood pressure medication if their blood pressure exceeds 150/90, which sets a higher bar ...
Tags: Health News, New Blood Pressure Guidelines, Bar for Taking Medications
A "misfire" is the way Eric Topol, MD, describes 23andMe's recent regulatory tussle with the FDA, which resulted in the Silicon Valley-based company halting sales for now of its health-related genetic test analysis. Speaking with MPMN ...
Tags: 23andme, FDA, regulatory tussle